Michael P. LaValley

Leveraging win time endpoint and combining moderators for personalized treatment recommendation in time-to-event clinical trials

Abstract Background There has been increasing interest in randomized trials on the discovery and identification of treatment moderators on an outcome. This reflects the stratified medicine paradigm, which moves beyond average treatment effects to focus on patient subgroups with h...